| 1. |
Baraniuk, J. N. (2000)Immunology and Allergy Clinics of North America (Lasley, M. and V. Altman, L. C. eds.), Saunders, Philadelphia, pp. 245–64.
|
| |
| 2. |
Baraniuk, J. N., Staevska, M. (2004) Current Therapy in Allergy Immunology and Rheumatology (Lichtenstein, L. M., Busse, W. W. and Geha, R. S., eds.), Mosby, Philadelphia, pp. 17–24.
|
| |
| 3. |
Meyer, P.,Andersson, M.,Persson, C.G., and Greiff, L. (2003) Steroid-sensitive indices of airway inflammation in children
with seasonal allergic rhinitis. Pediatr. Allergy Immunol.
14, 60–65
|
| |
| 4. |
Dahl, R., and Mygind, N. (1998) Mechanisms of airflow limitation in the nose and lungs. Clin. Exp. Allergy
28, 17–25.
|
| |
| 5. |
Svensson, C., Andersson, M.,Greiff, L., and Persson, C.G. (1998) Nasal mucosal end organ hyperresponsiveness. Am. J. Rhinol.
12, 37–43.
|
| |
| 6. |
Baraniuk, J. N., Ali, M.,Yuta, A., Fang, S-Y., and Naranch, K. (1999) Hypertonic saline nasal provocation stimulates nociceptive
nerves, substance P release, and glandular mucus exocytosis in normal humans. Am. J. Respir. Crit. Care Med.
160, 655–62.
|
| |
| 7. |
Sanico, A. M., Philip, G., Lai, G. K., and Togias, A. (1999) Hyperosmolar saline induces reflex nasal secretions, evincing
neural hyperresponsiveness in allergic rhinitis. J. Appl. Physiol.
86, 1202–10.
|
| |
| 8. |
Baraniuk, J. N., Clauw, D. J., and Gaumond, E. (1998) Rhinitis symptoms in chronic fatigue syndrome. Ann. Allergy Asthma Immunol.
81, 359–65.
|
| |
| 9. |
Fukuda, K., Straus, S. E., Hickei, I., Sharpe, M. C., Dobbins, J. C., and Komaroff, A. (1994) The chronic fatigue syndrome:
a comprehensive approach to its definition and study. Ann. Intern. Med.
121, 953–9.
|
| |
| 10. |
Tabaton, M., Monaco, S., Cordone, M. P., Colucci, M., Giaccone, G., Tagliavini, F., and Zanusso, G. (2004) Prion deposition
in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann Neurol.
55, 294–6.
|
| |
| 11. |
Sloat, B. R., and Cui, Z. (2005) Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective
antigen protein incorporated in liposome-protamine-dna particles. Pharm Res. it. Dec 6; [Epub ahead of print]
|
| |
| 12. |
Lindahl, M., Stahlbom, B., and Tagesson, C. (1995) Two-dimensional gel electrophoresis of nasal and onchoalveolar lavage fluids
after occupational exposure. Electrophoresis
16, 1199–1204.
|
| |
| 13. |
Lindahl, M., Stahlbom, B., Svartz, J., and Tagesson, C. (1998) Protein patterns of human nasal and bronchoalveolar lavage
fluids analyzed with two-dimensional gel electrophoresis. Electrophoresis
19, 3222–29.
|
| |
| 14. |
Lindahl, M., Stahlbom, B., and Tagesson, C. (1999) Newly identified proteins in human nasal and bronchoalveolar lavage fluids:
potential biomedical and clinical applications. Electrophoresis
20, 3670–76.
|
| |
| 15. |
Lindahl, M., Svartz, J., and Tagesson, C. (1999) Demonstration of different forms of the anti-inflammatory proteins lipocortin-1
and Clara cell protein-16 in human nasal and bronchoalveolar lavage fluids. Electrophoresis
20, 881–90.
|
| |
| 16. |
Ghafouri, B.,Stahlbom, B., Tagesson, C., and Lindahl, M. (2002) Newly identified proteins in human nasal lavage fluid from
non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics
2, 112–20.
|
| |
| 17. |
Lindahl, M., Stahlbom, B., andTagesson, C. (2001) Identification of a new potential airway irritation marker, palate lung
nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser
desorption/ionization-time of flight. Electrophoresis
22, 1795–1800.
|
| |
| 18. |
Lindahl, M., Irander, K., Tagesson, C., and Stahlbom, B. (2004) Nasal lavage fluid and proteomics as means to identify the
effects of the irritating epoxy chemical dimethylbenzylamine. Biomarkers
9, 56–70.
|
| |
| 19. |
Casado, B., Pannell, L. K., Viglio, S., Iadarola, P. et al. (2004) Analysis of the sinusitis nasal lavage fluid proteome using
capillary liquid chromatography interfaced to electrospray ionization-quadrupole time of flight- tandem mass spectrometry.
Electrophoresis
25, 1386–93.
|
| |
| 20. |
Casado, B., Pannell, L. K., Iadarola, P.,Baraniuk, J.N. (2005) Identification of human nasal mucous proteins using proteomics.
Proteomics
5, 2949–59.
|
| |
| 21. |
Kristiansson, M. H., Lindh, C. H., and Jonsson, B. A. (2003) Determination of hexahydrophthalic anhydride adducts to human
serum albumin. Biomarkers
8, 343–59
|
| |
| 22. |
Kristiansson, M. H., Lindh, C. H., andJonsson, B. A. (2004) Correlations between air levels of hexahydrophthalic anhydride
(HHPA) and HHPA-adducted albumin tryptic peptides in nasal lavage fluid from experimentally exposed volunteers. Rapid Commun Mass Spectrom.
18, 1592–8.
|
| |
| 23. |
Ali, M., Maniscalco, J., and Baraniuk, J. N. (1996) Spontaneous release of submucosal gland serous and mucous cell macromolecules
from human nasal explants in vitro. Am. J. Physiol.
270, L595–L600.
|
| |
| 24. |
Baraniuk, J. N., Silver, P. B., Kaliner, M. A., and Barnes, P. J. (1994) Int. Arch. Allergy Immunol.
103, 202–8.
|
| |
| 25. |
Baraniuk, J. N., Okayama, M., Lundgren, J. D., Mullol, M. et al. (1990) Vasoactive
intestinal peptide in human nasal mucosa. J. Clin. Invest.
86, 825–31.
|
| |
| 26. |
Wu, H. C. H., Huang, H., Yeh, Lai-Su, L.,Barker, C. W. (2003) Protein family classification and functional annotation. Comput. Biol. Chem.
27, 37–47.
|
| |